1. 2-BUTANONE:
TN/synonyms: Ethyl ketone.
MEK, Methyl acetone, Methyl ethyl ketone.
OSHAP PEL: 200 ppm - 8 hr/day-40hr/wk
- PP/S
590 mg/m3 - 8 hr/day-40hr/wk-PP/S
300 ppm - exposure not to
exceed 15 min
885 mg/m3 - exposure not
to exceed 15 min
ATSDR MRL: 0.1 ppm - Ihalation,
less than 15 days
IDLH: 3,000 ppm
symptoms: Eye, nasal, throat,
and upper respiratory ittitation; Headaches;
Weakness; Lightheadedness;
Dizziness; Vomiting; Numbness of extremities;
Muscle weakness; Nausea;
Loss of coordination; Respiratory system effects;
Temporary blindness;
Fatigue; Nerve inflammation
behind the eyes. Suspected of causing Developmental effects.
End-point Targets: Central
nervous system, Lungs.
Potentiation: In combination
with other solvents it becomes a very hazardous neurotoxin.
Synergiatic effect; Off-gasses
formaldehyde when burned
Note: Research suggests
that humans are more sensitive than other species tested.
Classification: Organic
solvent (Ketone compound).
2. CYCLOHEXANONE;
TN/synonms: Cyclohexyl ketone,
Pimelic ketone.
PSHA PEL: 25 ppm - 8 hr/day-40hr/wk
- PP/S
100mg/m3 - 8 hr/day-40hr/wk
- PP/S
IDLH: 5,000 ppm
Symptoms; Eye and mucus
membrane irritation, Headaches, Unconsciousness due
to narcotic effects. Coma,
Dermatitis
Suspected of causing Birth
defects; Reproductive effects;
Developmental effects; Neonatal
lethality; Tearing; Weight loss; Lethargy; Unexpanded fetal lungs at birth;
Pulmonary damage, edema,
and hemorraging; Intestinal congestion
Incoordination; Tremors;
Hypothermia.
End-point Targets; Respiratory
system, Eyes, Skin, Central nervous system
Classification; Organic
solvent (Ketone compound).
Note: Neurotoxin.
3. ISOBUTYL ALCOHOL:
TN/Synonyms: IBA, Isobutanal,
Isopropylcarbinol, 2-Methyl-1-propanol.
OSHA PEL: 50 ppm - 8hr/day040hr/wk
- PP/S
150 mg/m3 - 8 hr/day-40hr/wk
- PP/S
IDLH: 8,000 ppm
Symptoms; Eye, nasal, throat,
and skin irritation; Cardiac arrhythmias and failure;
Central nervous system depression;
Chemical sensitivity; Coma: confusion; Cough;
Cracking skin; Death; Delirium;
Dermatitis; Diarrhea; Drowsiness; Gastrointestinal hemorrhages; Giddiness;
Glucose in urine; Headaches; Impaired performance;
Incoordination; Kidney damage;
Labored or difficulty breathing; Liver damage;
Muscle weakness; Nausea;
Pulmonary edema; Respiratory failure; Vertigo; Vomiting.
Suspected of causing Cancer.
End-point Targets; Eyes, Skin, Respiratory system.
4. ALCOHOLS, DENATURED
Acetaldehyde; n-Butyl alcohol;
sec-Butyl alcohol; Crotonaldehyde;
Ethanol; n-Hexane; Pyridine;
1,1,2,2,-Tetrachloroethane; and Zinc chloride.
5. ACETONE:
TN/synonyms: Dimethyl ketone,
Ketone propane, Propanone, 2-Propanone, beta- Ketopropane, Methyl ketone.
NIOSH REL: 250 ppm - 10hr/day-40hr/wk
590 mg/m3 - 10hr/day-40hr/wk
OSHA PEL: 750 - 8hr/day-40hr/wk
- PP/S
1,800 mg/m3 - 8 hr/day-40hr/wk
- PP/S
1,000 ppm - not to exceed
15 min
2,400 mg/m3 - not to exceed
15 min
IDLH 1,000 ppm
Symptoms; Eye, nasal, and
throat irritation; Belligerence; Blood poisoning;
Alcoholic psychosis; Boastfulness;
Bronchitis; Circulatory failure; Cold, pale skin; Coma; Collapse; Conjunctivitis;
Convulsions; Death; Defatting dermatitis; Dilated pupils; Dizziness; Double
vision; Drowsiness; Emotional liability; Exhilaration; Flushed face; Gastritis;
Gastroduodenitis;
Headaches; Hearing loss;
Heart rate over 100 beats per minute; Hypothermia;
Impaired or absent tendon
reflexes; Incontinence; Incoordination; Increased susceptibility to infection;
Inflammation of airway, stomach, and duodenum;
Liver injury; Loss of sensation;
Low blood pressure; Nausea; Peripheral vascular collapse; Pharyngitis;
Pneumonia; Profuse sweating; Rapid pulse;
Remorse; Renal lesions;
Respiratory failure; Restlessness; Sensory disturbances; Shock; Slowed
reaction time; Slurred speech; Stupor;
Talkativeness; Vertigo'
Vomiting blood; Vomiting; Weakness. Suspected of causing Adverse spermatoginic
effects, Low birth weight, Neonate lethality
End-point Target: Respiratory
system, Eyes, Skin.
Classification; Organic
solvent (Ketone compound), Polar volatile organic compounds.
Note: Found in the blood
and urine in diabetes and other metabolic disorders.
Neurotoxin.
6. URETHANE:
Aniline, Ethylenediamine,
N-Ethylmorpholine, Hydrazine, and Methylene chloride.
7.VINYL CHLORIDE;
TN/synonyms: Chloroethene,
Chloroethylene, Ethylene monochloride, Monochlorethylene, VC, Vinyl chloride
monomer, VCM, 1-Chloroethylene.
NIOSH: Carcinogen at any
exposure level. Reduce exposure to lowest reliably detectable concentration.
OSHA PEL: 1 ppm - 8hr/day-40hr/wk
5ppm - Ceiling limit, 15 min exposure
ATSDR MRL: 0.006 ppm - Inhalation,
more than 14 days
ACGIH: Confirmed human carcinogen.
IDLH: NIOSH - Carcinogen
Symptoms: Pulmonary and
kidney irritation; Abdominal pains; Abnormal chest x-rays; Abnormal decrease
in blood platelets; Acroosteolysis (dissolution of the finger tips); Autoimmune
responses similar to sclerosis; Benign uterine growths; Binds to IgG
protein; Blockage of blood vessels; Cancer (central nervous system, respiratory
tract, lymphatic and blood); Cyanosis of extremities; Death; Decreased
libido; Decreased respiratory function; Discomfort upon exposure to cold;
Dizziness; Drowsiness; Emphysema; Euphoria; Gastrointestinal bleeding;
Headaches; Impotency; Inhibits blood clotting; Joint and muscle pain; Liver
damage and enlargement; Loss of consciousness; Menstrual disturbances;
Nausea; Numbness; Ovarian
dysfunction, Pallor; Peripheral
neuropathy; Pregnant toxemia, Prolapsed genital organs; Pulmonary fibrosis;
Raynaud's phenomenon symptoms (aka Vinyl chloride disease); Scleroderma-like
skin changes; Systemic sclerosis; Scleroderma; Spontanious abortions Stiff
hands; Thickening of blood vessel
walls and skin; Weakness;
Autoimmune disease. Suspected of causing Birth defects, Testicular damage.
End-point Targets: Liver, Central nervous
system, Blood Lymphatic
system. Additives/Contaminants: Stabilized with
inhibitors such as phenol.
Note; Occupational exposure
of males has been associated with increased
rates of spontaneous abortions
in their spouses. Neurotoxin.
8. LACQUER THINNERS
sec-Butyl acetate, Cumene,
and Isobutyl acetate.
9. ETHYL ACETATE:
TN/synonyms: Acetic ester,
Acetic ether, Ethyl ester of acetic acid,
Ethyl ethanoate.
OSHA PEL: 400 ppm - 8hr/day-40her/wk
- PP/S
1,400 mg/m3 - 8hr/day-40hr/wk
- PP/S
IDLH: 10,000ppm
Symptoms: Eye, nasal, throat,
and respiratory irritation; Belligerence;
Boastfulness; Cold, painful
skin; Coma; Convulsions; Corneal abnormalities;
Death; Dermatitis; Dilated
pupils; Double vision; Drowsiness; Emotional
instability; Exhilaration;
Flushed face; Gastritis; Headaches; Heart rate
over 100 beats per minute;
Hypoglycemia; Hypothermia; Impaired motor
skills; Impaired or absent
tendon reflexes; Incontinence; In coordination;
Low blood pressure; Lung,
liver, kidney, and heart damage; Nausea; Partial
or complete loss of sensation;
Peripheral vascular reaction time; Slowed
respiration; Slurred speech;
Stupor; Talkativeness; Unconsciousness due to
narcotic effects; Vertigo;
Vomiting; Weakness. Suspected of causing Central
nervous system depression,
Death.
End-point Targets: eyes,
skin, Respiratory system.
Classification; Polar volatile
organic compounds.
Note: neurotoxin.
10. EPOXY RESINS:
Diglycidyl ether, Phthalic
anhydride, Triethylamine, and Trimellitic
anhydride.
13. PRINTING INKS:
Acetone; Aniline; Benzidine;
2-Butanone; alpha-Chloroacetophenone;
Cyclohexanone; diisobutyl
ketone; Dimethylformamide; Ethyl acetate; Ethyl
butyl ketone; Ethylene glycol;
n-Heptane; Isoamyl acetate; Isopropyl
acetate; Methyl n-amyl ketone;
Methyl cellosolve; 5-Methyl-3-heptanone;
2-Nitropropane; 2-Pentanone;
n-diisocyanate; 1/1/1/-Trichloroethane;
Triethylamine; and Trimellitic
anhydride.
14. TOLUENE:
TN/synonyms: Methylbenzene,
Methyl benzol, Phenyl methane, Toluol.
OSHA PEL: 100 ppm - 8 hr/day-40hr/wk
- PP/S
375 mg/m3 8 hr/day-40hr/wk
- PP/S
150 ppm - exposure not to
exceed 15 min
560 mg/m3 exposure not to
exceed 15 min
ATSDR MRL: 4 ppm - Inhalation,
less than 15 days
1 ppm - Inhalation, more
than 14 days
IDLH: 2,000 ppm
Symptoms Eye, skin, and
respiratory irritation; Abdominal pain; Anemia:
Birth defects; Central nervous
system dysfunction and depression: Coma:
Confusion: Death: Delirium:
Dermatitis: Dilated pupils: Dizziness:
Drowsiness: Dry skin: Emotional
instability; Enlarged liver; Euphoria;
Fatigue: Fetal anomalies
and developmental delay: Fetal central nervous
system dysfunction; Hallucinations:
Headaches: impaired reaction time,
perception, and motor control;
In coordination: Insomnia; Liver disorders
and injury; Mild to severe
toxic brain dysfunction; Muscle fatigue; Nausea;
Nervousness; Neurobehavioral
changes; Numbness, tingling, or prickling
sensation; Organic affective
syndrome; Psychosis; Tearing, Vertigo; Vision
disturbances; Vomiting;
Weakness.
Suspected of causing Blurred
vision, Involuntary eye movement, Tremors,
Staggering gait, Abnormal
electroencephalogram.
End-point Targets: Central
nervous system, Liver, Skin.
Classification: Organic
solvent, Polar volatile organic compounds.
Note: Historically established
as a neurotoxin.
15. METHYLENE CHLORIDE:
TN/synonyms: Dichloromethane,
Methylene dichloride, Narkotil 9tn),
Salaesthin (tn), Solmethine
(tn).
NIOSH: Carcinogen at any
exposure level. Reduce exposure to lowest possible
level
OSHA PEL: 500 ppm - 8hr/day-40hr/wk
- PP/S
1000 ppm - ceiling limit
2000 ppm - 5 min max peak
in any 2 hrs
ACGIH: Suspected human carcinogen.
ACGIH TLV: 50 ppm - 8hr/day-40hr/wk
175 mg/m3 - 8 hr/day-40hr/wk
ATSDR MRL: 1.0 ppm - Inhalation,
less than 15 days.
0.4 ppm - Inhalation, more
than 14 days.
IDLH: 5,000ppm
Symptoms: Eye, nasal, throat,
skin irritation; Fatigue; Weakness;
Sleepiness; Lightheadedness;
Dizziness: Reduced coordination; Limbs numb
and/or tingling; Nausea;
Death; Loss of consciousness; Liver and kidney
damage; Increase in serum
bilirubin; Partial or complete loss of sensation;
Decrease in psychomotor
skills and behavioral performance. Suspected of
causing Cancer (lung), Low
birth weight, Low sperm count, DNA damage,
Genetic mutations, Chromosomal
aberrations, Brain damage.
End-point Targets; Skin,
Cardiovascular system, Central nervous system.
Note: Does not easily burn.
Classification; Halogenated
organic compountd, Polar volatile organic
compounds.
Note: neurotoxin
16. FREON:
Carbon tetrachloride, Dichlorodifluoromethane,
Dichloromonofluoromethane,
Dichloromonofluoromethane,
Dichlorotetrafluoroethane,
Fluorotrichloromethane, Methyl chloride, and
Trifluorobromomethane.
17. SILICONE
Chlorobenzene; Cresols;
Isophorone; Methyl chloride; Stibine;
Tetrachloroethylene; Tin;
1,1,1,-Trichloroethane.
19. SOLDERING MATERIALS;
Antimony, Arsine, Cadmium,
Hydrazine, Lead, Silver, Tin, Triethylamine,
and Zinc chloride.
20. METAL CLEANERS:
2-Butoxyethanol; Cyanides;
Diacetone alcohol; Ethylene dichloride;
Ethylene glycol; Hydrogen
peroxide; Manganese; Methylene chloride; Naphtha;
Oxalic acid; Petroleum distillates;
Silver; 1,1,2,2,0Tetrachloroethane; and
Tetrachloroethylene
21. FORMALDEHYDE:
TN/sysnonyms: Quaternium
- 15, Methanal, Methyl aldehyde, Methylene oxide,
Formalin, Formaic aldehyde,
Formalith, Formol, Fyde, BVF, Morbicid,
Oxymethylene; Oxomethane,
Lysoform, Lofol, superlysoform, Fannoform,
Ivalon.
NIOSH: Carcinogen at any
exposure level
NIOSH REL: 0.016 ppm - 10hr/day-40hr/wk
0.100 ppm - ceiling limit
not to exceed 15 min
OSHA PEL: 1.000 ppm - 8
hr/day-40hr/wk - PP/S
2.000 ppm - exposure not
to exceed 15 min
0.500 ppm - requires medical
surveillance
NAS: There is no population
threshol for irritation effects.
NRC: Fewer than 20% but
perhaps more than 10% of the general population
may be suspectible to formaldehyde
and may react acutely at any exposure
level.
ACGIH: Suspected human carcinogen.
IDLH: 30 ppm
Symptoms; Eye, nasal, throat,
and pulmonary irritation; Acidosis; Acute sense of smell; Alters tissue
proteins; Anemia; Antibodies formation;
Apathy:
Blindness; Blood in urine;
Blurred vision; Body aches; Bronchial spasms; Bronchitis; Burns nasal and
throat; Cardiac impairment, palpitations and arrhythmias;
Central nervous system depression;
Changes in higher cognitive functions; Chemical sensitivity; Chest pains
and sightness; Chronic vaginitis; Colds; Coma; Conjunctivitis; Constipation;
Convulsions; Corneal erosion; cough; Death; Destruction of red blood cells;
Depression; Dermatitis;
Diarrhea; Difficulty concentrating; Disorientation;
Dizziness; DNA damage; Drowsiness
Ear aches; Eczema; Emotional upsets;
Ethmoid polypos; Fatigue;
Fecal bleeding; Fetal asphyxiation; Flu-like or cold-like illness; Frequent
urination with pain; Gastritis;
Gastrointestinal inflammation;
Headaches; Hemolytic anemia; Hemolytic hematuria; Hoarseness; Hyperactive
airway disease; Hyperactivity;
Hypomenstrual syndrome;
Immune system sensitizer; Impaired (shsort) attention span; Impaired capacity
to attain attention; Inability or difficulty swallowing; Inability to recall
words and nae=mes; Intestinal pain; Intrinsic asthma; Irritaability; Jaundice;
Joint pains,m aches, and swelling; Kidney pain; Larynbgeal spasm: Loss
of memory; Loss of sense smell; Loss of taste: Malaise; Menstrual and testicular
pain; Menstrual
irregularities; Metallic
taste; Muscle spasms and cramps: Nasal congestion, crusting, and mucosa
inflammation; Nausea; Nosebleeds; Numbness and
tingling of the forearms
and finger tips: Pale, clammy skin: Partial laryngeal paralysis: Pneumonia:
Post nasal drip: Pulmonary edema; Reduced
body temperature: Retarded
speech pattern: Ringing or tingling in the ear:
Schizophrenic-type symptoms;
Sensitivity to sound; Shock; Short term memory loss; Shortness of breath:Skin
lesions; Sneezing; Sore throat: Spacey feeling;
Speaking difficulty: Sterility:
Swollen glands; Tearing: thirst: Tracheitis:
Tracheobronchitis:Vertigo:
Vomiting blood: Vomiting: Wheezing. Suspected of causing Cancer,
Genetic mutations, Chromosomal damage.
End-point Targets: Respiratory
system, Eyes, Skin, Central nervous system,
Liver, Kidneys, Gastrointestinal
tract, Cardiovascular system. Metabolized as Formic acid.
Note: Will cross sensitize
to formic acid. Comparison of ciliostatic effects showed formaldehyde to
be the most toxic of the aldehydes. EPA estimates that 15 people in 1 million
will get cancer from lifetime exposure of 1 ppb. Neurotoxin.
23. PIGMENTS
Aniline, Antimony trioxide,
Arsenic, barium, Benzidine, Cadmium, Carbon monoxide, Chromium, Cobalt,
Cyanides, Diacetone alcohol, Dibutylphthalate, Dimethylformamide, Ethyl
acrylate, Lead, Mercury, Methyl cellosolve, Molybdenum, Nickel, p-Nitroaniline,
Nitrophenols, Oxalic acid, Phthalic anhydride, Selenium, Tellurium Titanium
dioxide, Tributyl phosphate, Trimellitic anhydride, Vanadium pentoxide,
and Zinc oxide.
26. ETHYLENE OXIDE:
TN?synonyms: Dimethylene
oxide; 1,2-Epoxy ethane: Oxirane: Dihydro-oxirene; Epoxyethane; Ethene
oxide; ETP Anprolene (tn)/ Oxyfune (tn); T-Gas (tn).
NIOSH: Carcinogen at any
exposure level.
NIOSH REL:< 0.1ppm -
10hr/day-40hr/wk 0.18 mg/m3 - 10hr/day-40hr/wk 5 ppm - cdeiling limit 9
mg/m3 - 15 min/day
OSHA PEL: 1 ppm - 8hr/day-40hr/wk
5ppm - 15-min Excursion
ACGIH: Suspected human carcinogen.
ATSDR MRL: 0.09 ppm - Inhalation,
more than 14 days
IDLH: 800 ppm Symptoms:
Eye, nasal and throat irritation; Bronchitis; Burns skin and eyes; Cancer
(Leukemia, stomach, pancreatic): Cataracts: Chromosomal aberrations; Cornieal
burns; Cyanosis; Decreased sperm coundt; Diarrhea; Electrcardiogram abnormalities;
Emphysema; Frostbite; Headaches; Hodgkin's disease; Impaired hand/eye coordination;
Labored or difficulty breathing; Memory loss; Nausea; Neuropathy; Numbness,
tingling, or prickling sensation; Peculiar taste; Peripheral neurophathy:
Pulmonary edema; Spontaneous abortion; Vomiting. Suspected of causing Nasal
mucosa inflammation, Epithelial tissue death, Respiratory lesions, Low
birth weight, Neonate lethality, Birth defects, Testicular degeneration,
Convulsions, Liver and kidney damage. End-point targets: Respiratory system,
Central nervous system.
27. CARBON BLACK
TN?sysonyms: Acetylene black,
Channel black, Furnace black, Lamp black, Thermal black.
NIOSH: Carcinogen AT ANY
EXPOSURE LEVEL.
OSHA PEL: 3.5 mg/m3 - 8
hr/day-40hr/wk Symptoms Unknown
Target organ: Unknown Note:
Present in Polycyclic aromatic hydrocarbons.
28. XYLENES:
TN/synonyms: Dimethylbenzene,
Eyolol, Methyl toluene, violet 3 (tn). Isomers: m-Xylene - 1,2-Dimethylbenezene;
1,3-Xylene; m-Dimethylbenzene:
m-Xyolol: m-Methyltoluene;
meta-Xylene. o-Xylene - 1,2-Dimethylbenezene: 1,2-Xylene;
o-Dimethylbenzene; o-Xyolol; o-Methyltoluene; ortho-Xylene. p-Xylene
- 1,4-"Dimethylbenezene: 1,4-Xylene; p-Dimethylbenzene; p-Xyolol;
p-Methyltoluene: para-Xylene; Scintillar (tn)
ASHA PEL: 100 ppm - 8 hr/day-40hr/wk
- PP/S 435 mg/m3 8hr/day-40hr/wk - PP/S 150 ppm - exposure not to exceed
15 min 655 mg/m3 exposure not to exceed 15 min
IDLH: 1,000 ppm Symptoms:
Eye nasal, throat, and respiratory irritation; Abdominal pain; Abnormal
electrocardiograms; Amnesia; Brain hemorrhage; Cardiac palpitations; confusion;
Corneal vacuolization; Death; Dermatitis; Dizziness; Drowsiness; Epileptic
convulsions; Excitement; Fatigue; Gastric
discomfort; Headaches; Impaired
ability to work with numbers, balance, pulmonary function, and reaction
times; Labored breathing; Lightheadedness;
Liver and kidney damage;
Loss of appetite and patience; Nausea; Pulmonary congestion, hemorrhaging,
edema and damage; Reduced coordination;
Respiratory failure; Short-term
memory loss; Staggering gait; Tremors;
Unconsciousness due to narcotic
effects; Ventricular fibrillation; Vomiting
Suspected of causing Birth
defects: Spontaneous abortions; Cerebral dysfunction; Blurred vision; Involuntary
eye movement
End-point Targets: Central
nervous system, Eyes, blood, Skin, gastrointestinal tract, Liver, Kidneys.
Mixed Xylenes usually contain
the three forms of xylenes and 6% to 15% ethylbenzene.
Classification: Organic
solvent, Polar volatile organic compounds.
Note: Neurotoxin.
29. Hexone:
TN/synonyms: Isobutyl Methyl
ketone, Methyl isobutyl ketone, 4-Methyl 2-pentanone,
MIBK
OSHA PEL: 50 ppm - 8hr/day-40herwk
- PP/S
205 mg/m3 - 8hr/day-40hr/wk
- PP/S
75 ppm - exposure not to
exceed 15 min
300 mg/m3 - exposure not
to exceed 15 min
IDLH: 3,000 ppm
Symptoms: Eye, nasal, throat
and mucus membrane irritation; Headaches; Nausea; Vomiting; Loss of appetite;
Diarrhea; Drowsiness: Dizziness: Loss
of balance; Weakness: Stomach
pain; Sore throat; Fatigue; Insomnia: intestinal pain: Enlarged liver;
Colitis; Unconsciousness due to narcotic effects; Coma; Dermatitis: Central
nervous system depression, Lightheadedness; Incoordination; somnolence;
Heartburn; Central nervous
system impairment.
End-point Targets: Respiratory
system, Eyes, Skin, Central nervous system.
Note: Occupational tolerance
seems to develop during the work week but is lost over the weekend. some
adverse effects have been noted below ASHA PEL.
Classification: Organic
solvent (Ketone compound).
32. RUBBER
Acetic acid; Acetone; Acetonitrile;
Acrylonitrile; Aluminum; Ammonia;
sec-Amyl acetate; Aniline;
Antimony trioxide; Asbestos; Barium; Benzene;
Benzyl chloride; 1,3-Butadiene;
n-Butyl alcohol; Butylamine; Calcium oxide;
Camphor; Carbon disulfide;
Chlorinated diphenyl; Chlorobenzene; Chloroform;
beta-Chloroprene; Chromium;
Crotonaldehyde; Decaborane; Dibornane;
o-Dichlorobenzene; 1,2-Dichloroethylene;
Diethylamine; Diglycidyl ether;
Dimethylamine Dimethylphthalate;
Ethanolamine; Ethylene dichloride;
N-Ethylmorpholine; Formaldehyde;
Furfural; Hexachloroethane; Hydroquinone;
Isopropylamine; Magnesium
oxide; Mesityl oxide; Mica; Molybdenum;
Morpholine; p-Nitrochlorobenzene;
Nitrophenols; n-Nitrosodimethylamine;
Oxalic acid; Paraldehyde;
p-Phenylene diamine; Phthalic anhydride;
Polychlorinated biphenyls;
Propylene dichloride; Propylene imine; Pyridine;
Quinone; Selenium; Styrene;
Sulfur monochloride; Tellurium;
1,1,2,2-Tetrachloroethane;
Tetrahydrofuran; Titanium dioxide; o-Toluidine;
Toluene; 1,1,2-Trichloroethane;
Triethylamine; Vanadium
pentoxide; Xylenes' Zinc
chloride; and Zinc oxide.
34. ZINC OXIDE:
OSHA PEL: 5mg/m3 - 8hr/day
- 40hr/wk
10mg/m3 - exposure not to
exceed 15 min
IDLH: NE
Symptoms: Sweet or metallic
taste, Dry throat, Cough, Chills, Fever, Tight chest, Labored or difficult
breathing, Rales, Reduced pulmonary function,
Blurred vision, Muscle cramps
and pain, Lower back pain, Nausea, Vomiting, Fatigue, Lassitude, Malaise,
Metal fume fever, Dermatitis, Boils,
Conjunctivitis, Gastrointestinal
disturbances, Pneumonia, Increase in leukocytes in the blood, Liver dysfunction,
Gastrointestinal inflammation, Yawning, Weakness, Body aches, Headaches.
End-point Targets: Respiratory
system, Skin.
Note: In one report, symptoms
didn't appear until after 6 months of
occupational exposure.
35. NAPTHA:
TN/synonyms: Crude solvent
coal tar naptha, High solvent naptha.
OSHA PEL: 100 ppm - 8hr/day
- 40hr/wk - PP/S
400 mg/m3 - 8hr/day - 40hr/wk
- PP/S
IDLH: 10,000 ppm
Symptoms: Eye, nasal, throat,
and skin irritation; Lightheadedness;
Headaches; Loss of appetite;
Dizziness; Indigestion; Nausea; Insomnia
End-point Targets: Respiratory
system, Eyes, Skin
Component: Cumene
Classification: Organic
solvent (Refined Petroleum)
36. PHENOL
TN/synonyms: Carbolic acid,
Hydroxybenzene, Monohydroxy benzene, Phenyl
alcohol, Phenyl hydroxide.
NIOSH REL: 5 ppm - 10her/day
- 40hr/wk
19 mg/m3 - 10hr/day - 40hr/wk
15.6ppm - ceiling limit,
15 min exposure
60 mg/m3 - ceiling limit,
15 min exposure
OSHA PEL: 5 ppm - 8hr/day
- 40hr/wk - PP/S
19 mg/m3 8hr/day - 40hr/wk
- PP/S
HSDB TOXS; Some individuals
may be hypersensitive with lethality or serious effects at very low exposures
IDLH: 250 ppm
Symptoms: Eye, nasal and
throat irritation; Abdominal pain; Cardiac arrhythmias and failure; Cardiovascular
collapse; Chemical odor on breath;
Chromosomal aberrations
and damage; Cold sweats: Collapse: Coma: Confusion:
Convulsions; Cyanosis; Dark
pigmentation of the ligaments, cartilage, and fibrous tissue; Dark urine;
Dermatitis; Diarrhea; Difficulty swallowing;
Dizziness; Excessive bilirubin
in blood; Excitement; Fainting; Frothing at nose and mouth; Genetic mutations;
Granules in red blood cells; Headaches;
Hemoglobin oxidizes to ferric
form; Hemolytic anemia; Hypothermia; Liver, kidney, and heart damage; Loss
of appetite; Low blood pressure Muscle
aches, pain, and twitching;
Nausea; Pallor; Profuse sweating; Pulmonaary edema; Renal infufficiency;
Ringing or tingling in the ear; Shallow
respiration; Shock; Skin
burnns; Spontaneous abortions; Tremors;
Unconsciousness; Vomiting:
Weak, irregular pulse; Weakness; Weight loss.
End-point Targets: Liver,
Kidneys, Skin
Derivative of Benzene.
Note: historically established
as a neurotoxin.
37. BENZENE
TN/synonyms: Benzol, Benzole,
Annulene, Benzeen Phenyl hydride, Coal naptha, Cyclohexatriene, Fenzen,
Phene, Pyrobenzol, Pyrobenzole, Polystream tn) Benzol 90 (tn).
NIOSH: Carcinogen at any
exposure level.
NIOSH REL: 0/1 ppm - 10hr/day-40hr/wk
1 ppm - exposure not to
exceed 15 min
OSHA PEL: 1 ppm - 8hr/day
- 40hr/wk - PP?S
5 ppm - exposure not to
exceed 15 min
ACGIH: Suspected human carcinogen.
TSDR MRL: .001 ppm - inhalation,
less than 15 days.
IDLH: 3,000 ppm
Symptoms; Eye, nasal, and
respiratory system irritation; Eye, skin, DNA, immune system, and chromosomal
damage; Abnormal decrease in white blood cells; Anemia; Antibody formation,
Aplastic anemia: Asphyxia; Blood diseases; Blurred vision; Bone marrow
depression, Bronchitis; Cancer (leukemia); Cardiac collapse; Central nervous
system depression; Cerebral swelling; Congestive gastritis; Convulsions;
Death; Decreased antibodies, leukocytes, erythrocytes, and platelets; Decreased
coordination; Delirium;
Dermatitis; Dizziness; Drowsiness;
Effects brain catecholamines; Euphoria; Fatigue; Gastritis; Giddiness;
Granular tracheitis; Headaches; Impaired
judgement; Kidney congestion;
Laryngitis; Lassitude: Leukocyte chromosomal aberrations; Lightheadedness;
Loss of appetite; Loss of balance; Menstral pain and disorders; Nausea;
Nervousness; Non-lymphocytic leukemia; Ovarian atrophy; Pallor; Paralysis;
Premature births; Pulmonary hemorrhage; Pyloric strictures; Underdevelopment
of organs or body; Vertigo; Vomiting;
Weakness. Suspected of causing
Birth defects.
End-point Targets: Blood,
Central nervous system, bone marrow, Skin, Eyes, Respiratory system.
Metabolites: Benzene oxide
oxepin, Muconic acid, Phenyl Mercapturic acid,
Pre-phenyl mercapturic acid,
Benzene oxide, Benzene glycol, Muconaldehyde,
Benzoquinone, Hydroquinone,
Phenol, Catechol, Trihydroxy benzene,
Glucuronide, Sulfate.
Classification: Organic
solvent.
Note: Historically established
as a neurotoxin.
References. . .
4. Denatured alcohols, 6.
Urethane, 8. Lacquer thinners, 10. Epoxy resin, 13. Printing inks, 16.
Freon, 17. Silicone 19. Soldering materials,
20. Metal cleaners, 23.
Pigments, and 32. Rubber. Wilson, C.: Chemical Exposure and Human Health:
A Reference to 314 Chemicals, with a Guide to Symptoms, and a Directory
of Organizations, 1993) McLFarland & Company, Jefferson, NC.
1. 2-Butanone:
U.S. Department of Health
and Human Services, Public Health Service, Centers for Disease Control,
National Institute for Occupational Safety and Health, "NIOSH Pocket Guide
to Chemical Hazards," June 1990, U.S.
Government Printing Office,
Washington, D.C.
U.S. Department of Health
and Human Services, Public Health Service,Agency for Toxic Substances
and Disease Registry, "Toxicology Profile for2-Butanone," July 1992,
Syracuse Research Corporation.
U.S. Department of Health
and Human Services, Public Health Service, Centers for Disease Control,
National Institute for Occupational Safety and
Health, "NIOSH Current Intelligence
Bulletin 48 - Organic Solvent Neurotoxicity, "March 31, 1987.
U.S. Department of Health
and Human Services, Public Health Service, Centers for Disease Control,
National Institute for Occupational Safety and
Health, "Regulations, Recommendations
and Assessments Extracted from RTECS: A Subfile of the Registry of Toxic
Effects fof Chemical Substances, " September 1986, U.S. Government Printing
Office
Platinum is used as a catalyst
in the manufacture of gel components and the elastomer shell of silicone
breast implants. Women exposed to silicone breast implants have platinum
levels that exceed that of the general population. In the human body implants
are exposed to stress and heat, which can cause deterioration and oxidation.
The oxidation states of the platinum indicate that the exposure may be
toxic. Platinum species remain in the body for a long time after implants
are removed. Platinum salts have been associated with carcinogenicity and
neurotoxicity.
Toxic
Silicone Poisoning - The TRUE Breast Implant Stories:
The TRUTH of the GREATEST TRAVESTY AGAINST WOMEN in the 20th century
To reveal to the "people"
what has actually happened to these women before and after implantation
and their sufferings and realizations concerning the manipulation of general
opinion and media interests by large corporations and the major cover-up
that has taken place in this medical device industry. There are thirty-eight
known chemicals in the manufacturing and contents of silicone gel filled
breast implants! These thirty-eight chemicals are all toxic alone
if inhaled, ingested, or even handled; some causing cancer, some causing
neurological damage; organ damage or tissue damages. Combined all
together; however, they become a “chemical soup” that the F D A, the government,
the National Institute of Medicine, the Judicial System, the manufacturers
and their public relations’ firms, their lawyers, and the medical community
have allowed to be classified as a “medical device” and “suitable for implantation”
in the 
human
body! In the “informed consent” papers one must sign before having
the surgery for implantation of these “medical devices” no where does it
state any information about this “chemical soup”, no where does it state
any of the damage that could take place with these toxic “things” in the
human body!
450,000
Siliconized Women Sue
In 1984, setting a precedent for all women with implants and silicone-associated
illnesses, a woman named Maria Stern won $1.5 million in damages for autoimmune
symptoms produced by her implants. Litigation momentum has been building
ever since. By 1995, an estimated 450,000 American women had qualified
to be part of a gigantic $4.25 billion class action suit against the silicone
implant manufacturers. Many of the injured women fell through the litigation
cracks in 1995 when Dow Corning, one of the principal defendants, declared
bankruptcy, thereby taking itself conveniently off the fiscal hook. But
now that Dow Corning has agreed to a smaller global settlement ($3.2 billion
allocated, announced in July 1998), perhaps some injured women will finally
receive at least some recompense.
As medical authorities and scientific experts continually downplay the
risks of implants and assert that no association between implants and symptoms
has been proven, the case for silicone implant toxicity is growing, fueled
in large measure by the fact-finding efforts of the Plaintiffís
Steering Committee (PSC) for the National Breast Implant Litigation, consolidated
in Birmingham, Alabama. This national committee, appointed by U.S. District
Court Judge Sam Pointer, is comprised of 17 attorneys from around the country.
The nationally consolidated cases are known as the Silicone Gel Breast
Implant Product Liability, Multi-District Litigation Action No. 926.Part
of the Committeeís job, according to Karen E. Read, chief staff
attorney for the PSC Office of Liaison Counsel, is to gather and organize
evidence suitable for use in any and all court actions against the silicone
implant makers. In legal terms, itís called discovery. learn
more
Since their introduction in 1962, silicone breast implants have been
surgically emplaced in an estimated two million American women. Some women
get them as part of breast reconstruction therapy following mastectomy
for breast cancer, but the majority get them because they want larger breasts.
Now, 36 years later, it is alarmingly apparent that bigger, siliconized
breasts can be hazardous to your health. Weíre beginning to see
that the real cost of cosmetic breast enhancement may not be the $6,000
in surgical fees to implant them, but a host of autoimmune
symptoms and strange illnesses that can crop up, typically within about
seven years of implantation. Breast pain, breast hardness, and numbness
in the nipple are common complications that 
may
last for years, and may never go away. Breast pain, breast hardness,
and numbness in the nipple are common complications that may last for years,
and may never go away. Scientific
evidence proves that: Silicone breast implants can produce autoimmune
illnesses
Science
On Trial: The Clash pf Medical Evidence and the Law in the Breast Implant
Case
Angell, executive editor
of the New England Journal of Medicine, explores here a preposterous situation:
an industrial giant, Dow Corning, forced into Chapter 11 bankruptcy by
numerous lawsuits filed on behalf of recipients of Dow's silicone breast
implants?despite the fact that medical evidence to date shows no link between
implants and autoimmune disorders, cancer or any other disease. In a style
that ranges from gently didactic to plodding, Angell describes the events
leading up to the FDA's ban on implants, the torrent of lawsuits that followed
and the implications of the verdicts?overwhelmingly favorable to the plaintiffs
and often carrying cash awards in the millions of dollars?for science and
industry. Manufacturers have threatened to stop producing heart valves,
shunts and other vital medical devices because of the threat of liability;
further, suppliers of raw materials for these devices often refuse to sell
to American companies for fear of ending up in an American courtroom. The
author gives a clear explanation of the way science calculates risk (by
considering populations, not individuals) and ably contrasts this with
our judicial system, where the focus is on the individual seeking restitution.
Angell is an effective champion of the scientific method and does a good
job of exposing the chaos caused by a runaway tort system
Silicone
Spills: Breast Implants on Trial
"This is a tragic story of
big business, disinterested government, a powerful medical profession,
and certainly less powerful female consumers....
Arguing that pseudoscientific
theories of race from the 19th and early 20th centuries still impact our
current standards of beauty and "unhappiness" with our own bodies, prolific
critic Gilman (Difference and Pathology) explores plastic surgery as an
extension of psychotherapy. He traces the history of aesthetic surgery
from its initial function of hiding disease (most particularly syphilis)
to its later incarnation as a means of erasing ethnic identity (specifically
Jewish identifications by nose shape and size) and creating a more "normal"
appearance. Freud and other analysts were instrumental in establishing
theories of aesthetic surgery and, Gilman argues, "provided a label for
what it cured: inferiority." Several of Gilman's chapters are devoted to
tracing this intersection between theories of race, aesthetics and psychology
in the works of early psychoanalysts. Although his overarching argument
is compelling, Gilman's work relies heavily on technical language. This
work will be most useful to the surgeons and therapists who counsel people
seeking plastic surgery and to cultural critics interested in tracing mutations
in concepts of health, happiness and beauty. (Nov.) FYI: Also due in November
is Silicone Spill: Breast Implants on Trial, by Univ. of Nevada sociologist
Mary White Weaver, depicting the social, legal and health-care battles
fought by women with implant-related health problems.
Silicone
produces abnormalities in immune system functioning
Silicone elicits antibody responses and immunological abnormalities,according
to a study of 40 women who had received implants more than ten years earlier.
Among these women, 60% had an elevated ratio of helper T cells to suppressor
T cells; 20% had a blockage in particular functions of T cells and natural
killer cells. (Toxicology Industrial Health 8:6 [November/December
1992], 415-429.) Scientists at the University of California at Davis
reported that evidence suggests that the degradation products of silicone
inactivate CD8+ suppressor T cells (key immune cells) and thereby lead
to an inflammatory state in the body. (Food and Chemical
Toxicology 32:11 [November 1994], 1089-1100.) The activity of natural
killer cells is significantly suppressedin at least 50% of women with silicone
implants observed in a study; this puts the women at a higher risk of developing
cancer. The same effect was demonstrated in animals; it was reversed upon
removal of the silicone. (Toxicology and Industrial Health
10:3 [May/June 1994], 149-154.)
Kenneth
Bock, MD - "Because transfer factors can function
as immune system modulators, they can help to restore immune system balance
in many types of clinical situations."Kenneth Bock, MD, best selling author
on immune system modulation.
High levels of anti-nuclear antibodies (ANAs), immune markers associated
with lupus erythematosus, were observed in ten of 11 women with implants
reporting autoimmune
symptoms. (Lancet 340:8831 [November 28, 1992], 1304-1307.)
When 500 women with silicone implants were examined, 30% tested positive
for ANA levels; those women also had rheumatic symptoms. The results strongly
suggested immune activation in women with silicone implants.(Current
Topics in Microbiological Immunology 210 [1996], 277-282.) Based
on a study of 3,380 breast implant recipients, scientists state there is
a sixfold increased likelihood that testing these women will show elevated
ANAs; the longer the implant has been in place, the greater the likelihood.
(Current
Topics in Microbiological Immunology 210 [1996], 337-353.)
In a study of 111 women (with and without implants), those with implants
had a statistically significant elevationof anti-silicone antibodies (immune
cells focused against silicone as a foreign substance in the body); the
highest levels were observed in women with noticeable implant rupture or
leakage. (FASEB 7:13 [October 1993], 1265-1268.) Researchers
at the University of Wisconsin at Madison School of Medicine reported that
autoantibodies of unclear significance may be found in 5% to 30% of women
with silicone breast implants.(Archives of Internal Medicine
153:23 [December 1993], 2638-2644.) Researchers at Monash University
in Clayton, Victoria, in Australia, found that women with silicone implants
(70 were studied) have elevated levels of autoantibodies to collagen, in
a manner highly similar to women with lupus and rheumatoid arthritis. (Current
Topics in Microbiological Immunology 210 [1996], 307-316.)
Among 310 symptomatic women with silicone implants, there were elevated
levels of novel autoreactive antibodies to silicone associated antigens(a
specific type of heightened immune response) compared to healthy women
without implants. (Current Topics in Microbiological Immunology
210 [1996], 327-336.) Scientists at the Technical University of
Munich in Germany examined 239 breast implant recipients and found the
following immunological abnormalities: levels of complement C3 were elevated
in 42% of the women; complement C4 was elevated in 21%; and antithyroglobulin
(an antibody that attacks a substance in the thyroid gland) was higher
in 28%. (Annals of Plastic Surgery 36:5 [May 1996], 512-518.)
When silicone leaks from implants, immune cells form granulomas (microscopic
lumps) around the droplets; the granulomas are capable of severely disrupting
the immune system. Silicone plays the role of an adjuvant,providing constant
nonspecific stimulation of the immune system.(Journal of
Investigative Surgery 9:1 [January/February 1996], 1-12.)
Silicone produces a classifiable new disease marked by
autoimmune
symptoms
Among physicians willing to credit silicone with toxicological and immunological
effects, a variety of names for silicone-induced disease have been proposed:
siliconosis, undifferentiated or atypical connective tissue disease, silicone
related disease, silicone reactive disorder, silicone disease syndrome,
and silicone implant disease (SID). Typical symptoms associated with silicone
include cognitive dysfunction, short-term memory loss, Sjögrenís
syndrome (dryness in glands, such as the mouth, kidneys, eyes, and lungs),
scleroderma, rheumatoid arthritis, dermatomyositis, severe joint and muscle
pain, incapacitating fatigue, swollen lymph glands, skin problems, peripheral
numbness, multiple allergies, headaches, hair loss, sunlight sensitivity,
central nervous system disorders (similar to multiple sclerosis), and others.
Among
176 breast implant patients examined by doctors at the Hospital for Joint
Diseases, Orthopaedic Institute, in New York City, the most frequently
reported symptoms were chronic fatigue (77%), cognitive dysfunction (65%),
severe joint pain (56%), dry mouth (53%), dry eye (50%), hair loss (40%),
and difficulty in swallowing (35%). (Seminars in Arthritis
and Rheumatology 24:1 Suppl 1 [August 1994], 29-37.) A study of
50 women with implants revealed that 89% complained of fatigue, 75% of
generalized stiffness, 71% of poor sleep, and 78% of joint pain. Positive
ANAs were found in 38% of these patients. (Seminars in Arthritis
and Rheumatology 24:1 Suppl 1 [August 1994], 44-53.)
Richard
Bennett, PhD - "The immunity provided by transfer
factors is long lived and can help all ages who are suffering from
a variety of ailments or those who want to stay well.”
Silicone
is a biologically active and toxic substance
The
original statement by the Dow Chemical Company in the 1940s, repeated hundreds
of times since, that silicone is biologically inert and nontoxic, was based
on a single one-week study of rats and guineas pigs. (In 1943, Dow Chemical
Company and Corning Glassworks formed Dow Corning Corporation to market
silicone and silicone implants.)
The basic gel implant fillerñDC 360 silicone fluidñwas
once considered worth following upfor development by Dow Corning scientists
as a potent insecticide, one of the few known substances capable of killing
cockroaches. Dow Corning researchers also studied silicone as a possible
better chemical warfare and riot control agent,according to a 1969 internal
memorandum obtained by the PSC.
The silicone gel is not a single substance but a fluid comprised of
numerous different versions of silicone, such that it is better termed
a chemical soup.î
Research collected by the PSC shows that silicone has marked effects
on the adrenal glands and liver, induces chronic inflammation, and degrades
into smaller molecules, including silica. Silicone fed to rabbits produced
widespread toxic effects including kidney and spleen damage within four
months. (Stanford Medical Bulletin, 10:1 [1952], 23-26.)
That silicone is toxic in both animals and man is well proven,stated
John S. Sergent, M.D., and colleagues in Textbook of Rheumatology (W.B.
Saunders Company, 1993). Silicone degrades into silica, usually at the
surface of the gel implant, then fragments and subdivides into millions
of microdroplets capable of migrating throughout the body (PSC Records
No. 1352, 7017: these are documents produced by Dow Corning in national
litigation). Silica in the body is a toxic, carcinogenic substance, damaging
the immune system, killing cells, and producing silicosis.
Silicone and its contaminants which bleed through its surrounding implant
envelope into neighboring tissue have the potential for significant toxicity
in the implant recipient.(Seminars in Arthritis and Rheumatology 24:1 Suppl
1 [August 1994], 11-17.) According to research gathered by attorney
Richard Alexander, of the Alexander Law Firm in San Jose, California, Dow
Chemical and Dow Corning have been aware of the toxic effects of silicone
and silica since the 1950s, based on their own studies, but never published
the data. They knew these substances were bioreactive, immunogenic, toxic,
and inflammatory when introduced into the human body,states Alexander.
(Update on Breast Implants,January 1998, website: http://consumerlawpage.com.)
Researchers at the University of California at Los Angeles School of
Medicine concluded in 1995: From a pathophysiological perspective, silicones
should be expected to be bioactive materials and the physico-chemical and
immunological data at the experimental level are compelling.(Journal of
Biomaterials Science, Polymer Edition 7:2 [1995], 101-13.
HolisticWomen's Health:
-
Herbal treatment for Water Retention Edema (Excessive accumulation
of fluid in body tissues and cavities.)
-
Calcium and Strong Bones: Protecting Your Bones
-
Herbal and nutritional treatment for Cystitis (Acute or chronic
infection of the urinary bladder.)
-
Herbal, homeopathic and nutritional treatment for : Infertility,
CANDIDA, Thyroid disorder
-
Healthy Bones/Hip Fractures
-
Stress Reduction for Relief of Fibroids and Endometriosis
-
Homeopathy for Women's Health: Bladder Infections, Cramps, Breast
Cancer, Cystitis Hysterectomy, Menstruation, Uterine Fibroids, and much
more.
-
Herbal program to balance the hormonal system
Nutritional Medicine:
Life Stage Programs for Adult Women, for
Pregnancy, for Lactation, Vegetarian Diets for Pregnancy, and Life Stage
Programs for Menopause and Bone Health
Enter
-
Estrogen's Deadly Truth: a story
of deception, betrayal, hidden agendas, propaganda and misinformation.
"I saw these patients who were on estrogen and they were getting swollen
breasts and fibrosistic breast disease, they were getting fat around their
middle, their hips, their abdomen, losing libido and getting depressed."
Dr. John Lee
-
CANDIDA: Conquering Yeast Infections: The Non-Drug
Solution
-
Calcium and Strong Bones Study show
that women who got the most calcium from dairy products actually broke
more bones than women who rarely drank milk
-
Infertility and Miscarriage - the holistic
approach to infertility.
-
Homeopathy for Women's Health
-
Natural Weight Loss Programs: drugless approach
-
PMS and Menstrual Cramps - Lifting the Curse
of PMS
.
What
Every Parent Should Know BEFORE Their Childen Are Vaccinated! Why
are a growing number of parents and health care professionals around the
world questioning vaccination? The controversy stems from the thousands
of deaths and permanent disabilities attributed to vaccination annually,
as well as the many published medical studies, government statistics, congressional
testimonies, and other credible sources that directly contradict commonly
held assumptions about vaccine safety and effectiveness.
More pictures of vaccine damage available
to view at the
CDC
website
"Bart Classen,
a Maryland physician, published data showing that diabetes rates rose significantly
in New Zealand following a massive hepatitis B vaccine campaign in young
children, and that diabetes rates also went up sharply in Finland after
three new childhood vaccines were introduced." Nicholas
Regush ABCNEWS.com
In fall 1997, two influential
professional magazines featured articles asking the question: Has the decrease
of infectious diseases in childhood through the mass use of vaccines been
replaced with an increase in chronic diseases such as diabetes and asthma?
The Economist, a prestigious international magazine read by world leaders
in government, business and public policy, and Science News, a magazine
read by both health care professionals and the general public, explored
the reported links between vaccines and chronic diseases in their November
22, 1997 issues. Learn more about vaccine
and diabetes connection --- asthma and vaccine connection ---
SIDS
and autism and vaccine connection --- "Shaken Baby Syndrome":
the vaccination link
Congressman is calling
for criminal penalties for any government agency that knew about the dangers
of thimerosal in vaccines and did nothing to protect American children.
Congressman
Dan Burton (R-Indiana) during Congressional Hearing: "You mean to
tell me that since 1929, we've been using Thimerosal, and the only
test that you know of is from 1929, and every one of those people had mennigitis,
and they all died?" For nearly an hour, Burton repeatedly asked FDA and
CDC officials what they knew and when they knew it. (Thimerosal contains
a related mercury compound called ethyl mercury. Mercury is a toxic metal
that can cause immune, sensory, neurological, motor, and behavioral dysfunctions.)
Please get informed!Enter
the vaccine information site
Homeopathy
can be used successfully to prevent and treat smallpox, measles,
whooping
cough, chickenpox, and other ailments.
Would you allow big brother
to enforce vaccinations on your kids? Government
Enforced Vaccinations Vaccination Tracking Registry - Government programs
that limit your choices -and your rights- in health care when it comes
to mandatory vaccination. These mandates last for 40 or so years
and they're impossible to repeal. Also, learn about Legal Requirements
and Exemptions
Are we placing our animals
at risk too? Most recently, an article appeared in the Journal of the
American Veterinary Medical Association entitled
"Are We Vaccinating
Too Much?" Read the comments of veterinarians
who
believe that vaccines are damaging our pets.
Natural Health for
Women PART 1
Tell
Your Congressperson to Co Sponsor the Health Freedom Protection Act, H.R.
2117 This bill will stop the FDA & FTC longtime efforts of censorship
and restriction to access supplements and educational information.
